These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24376654)

  • 21. Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis.
    Engelbertsen D; Foks AC; Alberts-Grill N; Kuperwaser F; Chen T; Lederer JA; Jarolim P; Grabie N; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2526-35. PubMed ID: 26494229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.
    Yu X; Harden K; Gonzalez LC; Francesco M; Chiang E; Irving B; Tom I; Ivelja S; Refino CJ; Clark H; Eaton D; Grogan JL
    Nat Immunol; 2009 Jan; 10(1):48-57. PubMed ID: 19011627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TIGIT signalling pathway negatively regulates CD4
    Mao L; Hou H; Wu S; Zhou Y; Wang J; Yu J; Wu X; Lu Y; Mao L; Bosco MJ; Wang F; Sun Z
    Immunology; 2017 Jul; 151(3):280-290. PubMed ID: 28108989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIGIT regulates CD4
    Zhong X; Xie H; Wang S; Ren T; Chen J; Huang Y; Yang N
    Front Immunol; 2024; 15():1290564. PubMed ID: 38545097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression.
    Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E
    Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bidirectional effects of IL-10
    Douna H; Amersfoort J; Schaftenaar FH; Kroon S; van Puijvelde GHM; Kuiper J; Foks AC
    Atherosclerosis; 2019 Jan; 280():118-125. PubMed ID: 30500604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular B Cells Promote Atherosclerosis via T Cell-Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G.
    Tay C; Liu YH; Kanellakis P; Kallies A; Li Y; Cao A; Hosseini H; Tipping P; Toh BH; Bobik A; Kyaw T
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):e71-e84. PubMed ID: 29599140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.
    Koltsova EK; Kim G; Lloyd KM; Saris CJ; von Vietinghoff S; Kronenberg M; Ley K
    Circ Res; 2012 Oct; 111(10):1274-85. PubMed ID: 22927332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells.
    Kojima M; Suzuki K; Takeshita M; Ohyagi M; Iizuka M; Yamane H; Koga K; Kouro T; Kassai Y; Yoshihara T; Adachi R; Hashikami K; Ota Y; Yoshimoto K; Kaneko Y; Morita R; Yoshimura A; Takeuchi T
    Commun Biol; 2023 May; 6(1):500. PubMed ID: 37161050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIGIT Enhances Antigen-Specific Th2 Recall Responses and Allergic Disease.
    Kourepini E; Paschalidis N; Simoes DC; Aggelakopoulou M; Grogan JL; Panoutsakopoulou V
    J Immunol; 2016 May; 196(9):3570-80. PubMed ID: 27016609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
    Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice.
    Kolbus D; Ramos OH; Berg KE; Persson J; Wigren M; Björkbacka H; Fredrikson GN; Nilsson J
    BMC Immunol; 2010 Dec; 11():58. PubMed ID: 21126329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIGIT expression levels on CD4+ T cells are correlated with disease severity in patients with psoriasis.
    Wang FF; Wang Y; Wang L; Wang TS; Bai YP
    Clin Exp Dermatol; 2018 Aug; 43(6):675-682. PubMed ID: 29512851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Zhao M; Wigren M; Dunér P; Kolbus D; Olofsson KE; Björkbacka H; Nilsson J; Fredrikson GN
    J Immunol; 2010 Mar; 184(5):2253-60. PubMed ID: 20097865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherosclerosis Impairs Naive CD4 T-Cell Responses via Disruption of Glycolysis.
    Gaddis DE; Padgett LE; Wu R; Nguyen A; McSkimming C; Dinh HQ; Araujo DJ; Taylor AM; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2387-2398. PubMed ID: 34320835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterial heat shock protein 65 (mbHSP65)-induced atherosclerosis: Preventive oral tolerization and definition of atheroprotective and atherogenic mbHSP65 peptides.
    Grundtman C; Jakic B; Buszko M; Onestingel E; Almanzar G; Demetz E; Dietrich H; Cappellano G; Wick G
    Atherosclerosis; 2015 Sep; 242(1):303-10. PubMed ID: 26233917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
    Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
    Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.